CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,453,000 | +1558.4% | 376,583 | +695.6% | 0.16% | +1381.8% |
| Q2 2022 | $1,173,000 | +329.7% | 47,331 | +531.1% | 0.01% | +450.0% |
| Q4 2021 | $273,000 | -78.7% | 7,500 | -90.0% | 0.00% | -84.6% |
| Q3 2021 | $1,283,000 | +60.8% | 75,000 | +414.7% | 0.01% | -13.3% |
| Q3 2020 | $798,000 | -35.0% | 14,571 | -31.7% | 0.02% | -6.2% |
| Q2 2020 | $1,228,000 | – | 21,322 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |